425: Alchemy Investments Acquisition Corp 1 Faces Nasdaq Delisting

Alchemy Investments Acquisition Corp 1 will be delisted from Nasdaq on May 14, 2026, after failing to complete a business combination within the required 36-month timeframe.

Summary

• Alchemy Investments Acquisition Corp 1 received a delisting notice from Nasdaq on April 7, 2026.
• The company failed to meet the requirement of IM-5101-2, which mandates a business combination within 36 months of the IPO registration statement effectiveness.
• The IPO registration statement became effective on May 4, 2023, and the deadline for a business combination was May 4, 2026.
• The company has decided not to appeal the Nasdaq determination.
• Trading on Nasdaq will be suspended at the opening of business on May 14, 2026.
• The company expects its securities to transition to the over-the-counter (OTC) market on May 14, 2026.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative development, as the company has failed to execute its core business purpose, leading to a loss of its major exchange listing.

Positives

• The company has provided a clear path for continued trading on the over-the-counter market, maintaining liquidity for shareholders.

Negatives

• The company failed to complete a business combination within the 36-month window required by Nasdaq rules.
• The company is being delisted from the Nasdaq Stock Market.
• The company has chosen not to appeal the delisting decision.

Risks

• Loss of liquidity and potential decrease in valuation associated with moving from a major exchange to the over-the-counter market.
• Increased difficulty in raising future capital due to the loss of Nasdaq listing status.
• Potential for reduced institutional investor interest following the delisting.

Future Outlook

The company intends to transition its securities to the over-the-counter market following the suspension of trading on Nasdaq on May 14, 2026.

Industry Context

StockSavvy.ai notes that this event highlights the ongoing challenges faced by SPACs in the current regulatory and economic environment, where many entities are struggling to identify and close viable merger targets within the strict timeframes imposed by exchange listing rules.

Comparison to Industry Standards

• The failure to complete a business combination within the 36-month window is a common issue for SPACs that have been unable to find suitable acquisition targets in the current market.
• The decision not to appeal a delisting notice is standard practice for SPACs that have exhausted their time limit and lack a definitive merger agreement.

Stakeholder Impact

• Shareholders face reduced liquidity and potential volatility as the stock moves to the OTC market.
• The company's prestige and visibility are significantly diminished by the loss of the Nasdaq listing.

Next Steps

• Suspension of trading on Nasdaq on May 14, 2026.
• Commencement of trading on the over-the-counter market on May 14, 2026.
• Filing of Form 25-NSE with the SEC to finalize the removal from Nasdaq.

Key Dates

Recommendation

The failure to complete a business combination and the subsequent delisting from a major exchange typically signals a lack of viable strategic options, making the stock a high-risk hold or sell for most investors.

Keywords

SPAC, Delisting, Nasdaq, Alchemy Investments Acquisition Corp 1, Business Combination, OTC